Skip to Content

Anti-Fibrotic Drug Development Summit (AFDD)

Start Date:
Monday, 13 November, 2017
End Date:
Tuesday, 14 November, 2017 3:45pm
Speciality:
Ophthalmology
Website:
http://go.evvnt.com/147139-0

This Anti-Fibrotic Drug Development conference will be a unique opportunity for drug developers focused on organ-specific indications to participate in a cross-disciplinary, multi-organ discussions in order to gain new insights into their anti-fibrotic drug development research. Attending this comprehensive forum will enable you to; identify which fibrotic mechanisms are driving pathology changes in humans; effectively translate from preclinical to clinical development and robustly select patient populations.URL:Brochure: https://go.evvnt.com/147139-1Speakers: Ray Jupp (UCB), Richard Marshall (GSK), Lisa Hazelwood (AbbVie), Peter Blume-Jensen (Xtuit Pharmaceuticals), Alexey Lugovskoy (Morphic Therapeutics), Seth Porter (FibroGen)

Location

Hyatt Regency Boston,
One Avenue de Lafayette,
Boston,
02111,
United States.

Organizer Details

Conference organized by Hanson Wade

Phone:
02031418700
Email:
info@hansonwade.com

Medical conference data provided by Meetings4Docs | Report a problem

Image Gallery

Hide